000 01670 a2200493 4500
005 20250514205341.0
264 0 _c20050425
008 200504s 0 0 eng d
022 _a0085-2538
024 7 _a10.1111/j.1523-1755.2004.00985.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMasaki, Takahisa
245 0 0 _aInhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
_h[electronic resource]
260 _bKidney international
_cNov 2004
300 _a2061-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBlood Vessel Prosthesis
650 0 4 _aDogs
650 0 4 _aFemale
650 0 4 _aGraft Occlusion, Vascular
_xprevention & control
650 0 4 _aHyperplasia
_xprevention & control
650 0 4 _aMale
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aPolymers
650 0 4 _aPolytetrafluoroethylene
650 0 4 _aRenal Dialysis
650 0 4 _aTunica Intima
_xdrug effects
700 1 _aRathi, Ramesh
700 1 _aZentner, Gaylen
700 1 _aLeypoldt, John K
700 1 _aMohammad, Syed F
700 1 _aBurns, Gregory L
700 1 _aLi, Li
700 1 _aZhuplatov, Sergey
700 1 _aChirananthavat, Thanit
700 1 _aKim, Seung-Jung
700 1 _aKern, Steven
700 1 _aHolman, John
700 1 _aKim, Sung Wan
700 1 _aCheung, Alfred K
773 0 _tKidney international
_gvol. 66
_gno. 5
_gp. 2061-9
856 4 0 _uhttps://doi.org/10.1111/j.1523-1755.2004.00985.x
_zAvailable from publisher's website
999 _c15185793
_d15185793